Abstract
Purpose
The purpose of this study is to determine the burden of the peak severity of oral mucositis and severity over time on selected clinical outcomes in paediatric and adolescent patients receiving chemotherapy.
Patients and methods
A multicentre study enrolled 140 patients between the ages of 6 and 18 years, who had been treated with chemotherapy and completed the self-report Mouth and Throat Soreness-related questions of the Oral Mucositis Daily Questionnaire for 14 days. Clinical data were collected from patients' medical records during the first 14 days after starting chemotherapy.
Results
Forty-one percent developed oral mucositis. Multiple linear regression analysis revealed that oral mucositis was significantly associated with an increased loss of baseline body weight, after controlling for nausea/vomiting (β = 0.34, p = 0.002). Multiple logistic regression analysis showed that severe mucositis was significantly associated with a higher probability of fluid replacement, after controlling for nausea/vomiting (adjusted OR = 12.8; 95 % CI = 2.7–61.0; p = 0.001). In addition, severe mucositis was significantly associated with a higher probability of fever, after controlling for neutropoenia (adjusted OR = 5.4; 95 % CI = 1.8–15.4; p = 0.002). No difference was observed for oral or systemic infections among the subgroups. About 5 % of the patients with oral mucositis had delays in chemotherapy (≤7 days). None of the patients had dose modification or unplanned hospitalization due to oral mucositis. The associations of peak severity and overall oral mucositis with adverse clinical outcomes in paediatric and adolescent patients were equivalent.
Conclusion
Oral mucositis is associated with negative effects on clinical outcomes.
Similar content being viewed by others
References
Linabery AM, Ross JA (2008) Trends in childhood cancer incidence in the U.S. (1992–2004). Cancer 112:416–432
Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert M, Hauer-Jensen M et al (2004) Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 100(Suppl):1995–2025
Cheng KKF (2009) Oral mucositis: a phenomenological study of pediatric patients' and their parents' perspectives and experiences. Support Care Cancer 17:829–837
Cheng KKF, Lee V, Li CH, Goggins W, Thompson DR, Yuen HL et al (2011) Incidence and risk factors of oral mucositis in paediatric and adolescent patients undergoing chemotherapy. Oral Oncol 47:153–162
Anirudhan D, Bakhshi S, Xess I (2008) Etiology and outcome of oral mucosal lesions in children on chemotherapy for acute lymphoblastic leukemia. Indian Pediatr 45:47–51
Cruz LB, Ribeiro AS, Rech A (2007) Influence of low-energy laser in the prevention of oral mucositis in children with cancer receiving chemotherapy. Pediatr Blood Cancer 48:435–440
Fadda G, Campus G, Luglie P (2006) Risk factors for oral mucositis in paediatric oncology patients receiving alkylant chemotherapy. BMC Oral Health. doi:10.1186/14726831613
Figliolia SLC, Oliveira DT, Pereira MC (2008) Oral mucositis in acute lymphoblastic leukaemia: analysis of 169 paediatric patients. Oral Dis 14:761–766
Elting LS, Cooksley C, Chambers M, Cantor SB, Manzullo E, Rubenstein EB (2003) The burdens of cancer therapy: clinical and economic outcomes of chemotherapy-induced mucositis. Cancer 98:1531–1539
Cheng KKF, Lee V, Li CH, Yuen HL, Epstein JB (2012) Oral mucositis in pediatric and adolescent patients undergoing chemotherapy: the impact of symptoms on quality of life. Support Care Cancer 20:2335–2342
Isitt J, Murphy BA, Beaumont JL, Garden AS, Gwede CK, Trotti A et al (2007) Oral mucositis-related morbidities and resource utilization in a prospective study of head and neck cancer patients. J Support Oncol 5:54–55
Nonzee NJ, Dandade NA, Markossian T, Agulnik M, Argiris A, Patel JD et al (2008) Evaluating the supportive care costs of severe radiochemotherapy-induced mucositis and pharyngitis. Cancer 113:1446–1452
Elting L, Cooksley CD, Chanbers MS, Garden AS (2007) Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies. Int J Radiat Oncol Biol Phys 68:1110–1120
Fanning SR, Rybicki L, Kalaycio M (2006) Severe mucositis is associated with reduced survival after autologous stem cell transplantation for lymphoid malignancies. Br J Haematol 135:374–381
Sonis ST, Oster G, Fuchs H, Bellm L, Bradford WZ, Edelsberg J et al (2001) Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. J Clin Oncol 19:2201–2205
Cheng KKF, Lee V, Li CH, Yuen HL, Ip WM, Epstein JB (2012) Oral Mucositis Daily Questionnaire for older child and adolescent receiving chemotherapy: psychometric evaluation. Support Care Cancer 20:S39
Stiff PJ, Erder H, Bensinger WI, Emmanouilides C, Gentile T, Isitt J et al (2006) Reliability and validity of a patient self-administrated daily questionnaire to assess impact of oral mucositis on pain and daily functioning in patients undergoing autologous hematopoietic stem cell transplantation. Bone Marrow Transpl 37:393–401
Tomlinson D, Ethier MC, Judd P, Doyle J, Gassas A, Naqvi A et al (2011) Reliability and construct validity of the oral mucositis daily questionnaire in children with cancer. Eur J Cancer 47:383–388
Trotti A, Bellm LA, Epstein JB, Frame D, Fuchs HJ, Gwede CK et al (2003) Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic review. Radiother Oncol 66:253–262
Keefe DM, Rassias G, O’Neil L, Gibson RJ (2007) Severe mucositis: how can nutrition help? Curr Opin Clin Nutr Metab Care 10:627–631
Elting LS, Keefe DM, Sonis ST, Garden AS, Spijkervet FKL, Barasch A et al (2008) Patient-reported measurements of oral mucositis in head and neck cancer patients treated with radiotherapy with or without chemotherapy: demonstration of increased frequency, severity, resistance to palliation, and impact on quality of life. Cancer 113:2704–2713
Epstein JB, Epstein JD, Epstein MS, Oien H, Truelove EL (2006) Oral doxepin rinse: the analgesic effect and duration of pain reduction in patients with oral mucositis due to cancer therapy. Anesth Analg 103:465–470
White MC, Hommers C, Parry S, Stoddart PA (2011) Pain management in 100 episodes of severe mucositis in children. Pediatr Anesth 21:411–416
Sonis ST (2009) Mucositis: the impact, biology and therapeutic opportunities of oral mucositis. Oral Oncol 45:1015–1020
Acknowledgments
This study was supported by a grant from the Health, Welfare and Food Bureau of Hong Kong. We thank the physicians and nursing staff who were involved in various aspects of this study. Our special thanks go to all patients and their parents who gave their time to this study.
Conflicts of interest
None of the authors has any financial and personal relationships with other people or organizations that could inappropriately influence their work.
Author information
Authors and Affiliations
Corresponding author
Additional information
This study was supported by the Health and Health Services Research Fund of the Health, Welfare and Food Bureau of Hong Kong.
Rights and permissions
About this article
Cite this article
Cheng, K.K.F., Lee, V., Li, C.H. et al. Impact of oral mucositis on short-term clinical outcomes in paediatric and adolescent patients undergoing chemotherapy. Support Care Cancer 21, 2145–2152 (2013). https://doi.org/10.1007/s00520-013-1772-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-013-1772-0